1. Bisphosphonate holidays: using cost-effectiveness analysis for the “yes, but” questions

   • C.S. Colón-Emeric
   • R.H. Lee

   Editorial 13 September 2021 Pages: 2389 - 2390

2. Where’s the break? Critique of radiographic vertebral fracture diagnostic methods

   • J. C. Prior
   • E. H. G. Oei
   • Brian C. Lentle

   Editorial Open access 21 October 2021 Pages: 2391 - 2395

   

3. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism

   • P. Evenepoel
   • J. Cunningham
   • and the committee of Scientific Advisors and National Societies of the IOF

   Review 15 June 2021 Pages: 2397 - 2405

   

4. Metabolomic biomarkers of low BMD: a systematic review

   • N. Panahi
   • B. Arjmand
   • B. Larijani

   Review 26 July 2021 Pages: 2407 - 2431

   

5. Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies

   • G. Valentin
   • M.B. Ravn
   • C.L. Gregson

   Review 25 June 2021 Pages: 2433 - 2448

   

6. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis

   • L. dos Santos Ferreira
   • L. G. Abreu
   • A. C. U. Vasconcelos

   Review 31 July 2021 Pages: 2449 - 2459

   

7. Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?

   • L. Masi
   • F. Marini
   • M. L. Brandi

   Original Article Open access 07 June 2021 Pages: 2461 - 2472

   

8. Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage

   • A.J. Singer
   • J. Liu
   • A. Yehoshua

   Original Article Open access 07 June 2021 Pages: 2473 - 2484

   

9. Excess mortality after hip fracture: fracture or pre-fall comorbidity?

   • M.H.L. Liow
   • G. Ganesan
   • K.B. Tan

   Original Article 15 June 2021 Pages: 2485 - 2492

   

10. Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis

    • M. Zhu
    • P. Yin
    • S. Wang

    Original Article Open access 17 June 2021 Pages: 2493 - 2503

    

11. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa

    • L. Seefried
    • D. Rak
    • F. Genest

    Original Article Open access 02 July 2021 Pages: 2505 - 2513

    

12. Trends and regional variation in vertebroplasty and kyphoplasty in Switzerland: a population-based small area analysis

    • A.N. Frei
    • W.F. Gellad
    • D. Aujesky

    Original Article Open access 22 June 2021 Pages: 2515 - 2524

    

13. Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up

    • S. N. Morin
    • L. Yan
    • W. D. Leslie

    Original Article 24 June 2021 Pages: 2525 - 2532

    

14. Exercise-induced hypercalcemia and vasopressin-mediated bone resorption

    • M. Senda
    • T. Hamano
    • T. Moriyama

    Original Article 17 June 2021 Pages: 2533 - 2541

    

15. Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data

    • J. Ha
    • C. Jeong
    • K.-H. Baek

    Original Article 31 July 2021 Pages: 2543 - 2553

    

16. Survival bias may explain the appearance of the obesity paradox in hip fracture patients

    • R.M. Amin
    • M. Raad
    • D.F. Amanatullah

    Original Article 10 July 2021 Pages: 2555 - 2562

17. “Fear of falling serves as protection and signifies potential danger”: a qualitative study to conceptualise the phrase “fear of falling” in women with osteoporosis

    • K. Hamed
    • K.S. Roaldsen
    • A. Halvarsson

    Original Article Open access 07 July 2021 Pages: 2563 - 2570

18. Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study

    • C.-C. Lin
    • C.-I. Li
    • T.-C. Li

    Original Article 06 July 2021 Pages: 2571 - 2582

    

19. Diffuse adverse cutaneous reactions induced by zoledronic acid administration: a case report

    • Kawtar Nassar
    • Saadia Janani

    Case Report 03 June 2021 Pages: 2583 - 2586

    

20. Hypercalcemia in non-Hodgkin’s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D

    • A.R. Gonciulea
    • Y. Wang
    • D.E. Sellmeyer

    Case Report 06 July 2021 Pages: 2587 - 2592

    

21. RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans

    • R. M. Aspden

    Letter to the Editor 19 October 2021 Pages: 2593 - 2594

22. Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans"

    • F. Jazinizadeh
    • J. Adachi
    • C. Quenneville

    Letter to the Editor 19 October 2021 Pages: 2595 - 2595

23. Comment on “Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies”

    • T. Chen
    • R. Jiang
    • L. Jiang

    Letter to the Editor 21 October 2021 Pages: 2597 - 2598

    

24. Risk factors for hip fracture

    • Shih-Wei Lai

    Letter to the Editor 04 October 2021 Pages: 2599 - 2599

25. Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.

    • A. Deminger
    • E. Klingberg
    • H. Forsbladd’Elia

    Publisher Correction Open access 02 November 2021 Pages: 2601 - 2601